Filtered By:
Management: Insurers

This page shows you your search results in order of date. This is page number 8.

Order by Relevance | Date

Total 120 results found since Jan 2013.

Boston Scientific dips on Medicare reimbursement hit for Watchman anti-stroke device
Boston Scientific (NYSE:BSX) shares took a hit yesterday after a Centers for Medicare & Medicaid Services proposal that would limit coverage for the Watchman anti-stroke device. Investors also likely reacted to a pair of Class II recalls from the FDA, sending BSX shares down -4.2% to $18.01 apiece yesterday. Watchman, a transcatheter implant designed to seal off the left atrial appendage to prevent the formation of blood clots that could cause stroke, was approved by the FDA in March and asked for a CMS coverage decision in May. The federal health insurer proposed to limit coverage for Watchman to patients in approv...
Source: Mass Device - November 12, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Cardiac Implants Cardiovascular Recalls Boston Scientific Cardiac Rhythm Management Stroke Source Type: news

Cost-Effectiveness of Dabigatran (150 mg Twice Daily) and Warfarin in Patients ≥65 Years With Nonvalvular Atrial Fibrillation
Dabigatran has been shown to be superior to warfarin for stroke prevention in nonvalvular atrial fibrillation (NVAF) but with higher out-of-pocket costs for patients. Although dabigatran has been shown to be cost effective from a societal perspective, cost implications for individual patients and insurers are not well described. We aimed to assess cost perspectives of each payer (Medicare and patient) in relation to administration, monitoring, and adverse outcomes for dabigatran and warfarin in patients with and without prescription drug coverage.
Source: The American Journal of Cardiology - October 16, 2015 Category: Cardiology Authors: Brian M. Salata, David W. Hutton, Deborah A. Levine, James B. Froehlich, Geoffrey D. Barnes Tags: Arrhythmias and Conduction Disturbances Source Type: research

Cost-Effectiveness of Dabigatran (150 mg Twice Daily) and Warfarin in Patients ≥ 65 Years with Non-Valvular Atrial Fibrillation
Dabigatran has been shown to be superior to warfarin for stroke prevention in non-valvular atrial fibrillation (NVAF) but with higher out-of-pocket costs for patients. Although dabigatran has been shown to be cost-effective from a societal perspective, cost implications for individual patients and insurers are not well-described. We aimed to assess cost perspectives of each payer (Medicare and patient) in relation to administration, monitoring and adverse outcomes for dabigatran and warfarin in patients with and without prescription drug coverage.
Source: The American Journal of Cardiology - October 16, 2015 Category: Cardiology Authors: Brian M. Salata, David W. Hutton, Deborah A. Levine, James B. Froehlich, Geoffrey D. Barnes Source Type: research

Autism in the Son of a Woman with Mitochondrial Myopathy and Dysautonomia: A Case Report
Conclusion Given emerging evidence that mitochondrial dysfunction, particularly in the electron transport chain needed for cellular energy production, is an underlying pathophysiological mechanism for some varieties of ASD, clinicians should have a high index of suspicion for mitochondrial disease, especially when they encounter a patient with unusual neurological or constitutional symptoms. The prevalence of mitochondrial disease in ASD patients may be as high as five percent, which means that it is not the “zebra”[27] diagnosis that it might be in a non-ASD patient, where prevalence is about 0.01 percent.10 Reference...
Source: Innovations in Clinical Neuroscience - October 9, 2015 Category: Neuroscience Authors: ICN Online Editor Tags: Anxiety Disorders Asperger's syndrome Autism Behavioral and Cognitive Neurology Case Report Current Issue Intellectual Disability Neurologic Systems and Symptoms Pervasive Developmental Disorders ASD autism spectrum disorder dysauton Source Type: research

Can Oxygen Therapy Bring Dead Brain Cells Back To Life?
During my Palm Beach Anti-Aging Summit in October, I’m hosting some of the world’s leading authorities on oxygen therapy. The Summit coincides with the grand opening of my 17,000-sq.-ft. Sears Institute for Anti-Aging Medicine, where I’m unveiling a specially-designed room that houses my first hyperbaric oxygen chamber. I hope you’ll be there, as you’ll discover the newest applications and breakthroughs in this growing field. You see, when oxygen is pressurized — like it is when you’re inside the chamber — you can treat more than just chronic disease. Truth is, hyperbaric oxygen can...
Source: Al Sears, MD Natural Remedies - September 14, 2015 Category: Complementary Medicine Authors: Dr. Al Sears Tags: Brain Health brain cells hyperbaric oxygen chamber natural treatment omega-3 fatty acids Palm Beach Anti-Aging Summit Source Type: news

New Oral Anticoagulants: How Do We Use Them Wisely?
Abstract The relative efficacy and safety of new oral anticoagulants (NOAC) have been consistent across a wide range of patients in clinical trials. On the one hand, they have offered new therapeutic options for stroke prevention in patients with atrial fibrillation (AF) and patients do like the experience of no need of frequent blood draws. On the other hand, their expensive prices, different formulary plans from different insurance companies, lack of antidote, and no method of monitoring the therapy are some of the challenges on their use in clinical practice. This narrative review aims to help clinicians under...
Source: Current Cardiology Reports - August 3, 2015 Category: Cardiology Source Type: research

Work Wellness Programs May Soon Include Genetic Testing
Your employer may one day help determine if your genes are why your jeans have become too snug. Big companies are considering blending genetic testing with coaching on nutrition and exercise to help workers lose weight and improve their health before serious conditions like diabetes or heart disease develop. It's a step beyond the typical corporate wellness programs that many companies are using to make workers more aware of their risk factors and improve their health. Genetic testing in corporate wellness programs also is relatively uncharted territory. Many employers and insurers cover these tests and counseling for med...
Source: Science - The Huffington Post - April 29, 2015 Category: Science Source Type: news

Mortality outcomes in hospitals with public, private not-for-profit and private for-profit ownership in Chile 2001-2010
Discussion: The question about which type of hospital ownership performs better in Chile remains open. Policy decisions regarding health service provision requires more evidence explaining differences by ownership. Better controls for health risk and hospital characteristics are suggested to address these differences in hospital performance.
Source: Health Policy and Planning - March 10, 2015 Category: Health Management Authors: Cid Pedraza, C., Herrera, C. A., Prieto Toledo, L., Oyarzun, F. Tags: Original articles Source Type: research

Risk of osteoporotic fractures following stroke in older persons
Conclusion To evaluate the relative risk of stroke survivors for osteoporotic fractures, functional status appears to be a relevant parameter.
Source: Osteoporosis International - January 8, 2015 Category: Orthopaedics Source Type: research

Secondary stroke prevention in atrial fibrillation: a challenge in the clinical practice
Background: Despite clear evidence for the effectiveness of oral anticoagulation (OA) in patients with atrial fibrillation (AF), there is evidence for the underutilisation of this therapy in the secondary stroke prevention. We therefore investigate the link between the use of OA in stroke patients with AF and favourable clinical outcome following the acute event. Methods: The study population was determined by identifying the overlap of two different databases: a stroke registry and claims data of a health insurance company. Baseline data originated from the registry; documented dementia and the prescriptions for OA were d...
Source: BMC Neurology - September 30, 2014 Category: Neurology Authors: Christian TanislavSonja MildeSabine SchwartzkopffNicole SiewekeHeidrun KrämerMartin JuenemannBjörn MisselwitzManfred Kaps Source Type: research

Should health insurers target prevention of cardiovascular disease?: a cost-effectiveness analysis of an individualised programme in Germany based on routine data
Conclusion: The cost-effectiveness of KardioPro differs substantially according to the group being targeted. Depending on the willingness-to-pay, it may be reasonable to only offer KardioPro to patients at high risk of further cardiovascular events. This high-risk group could be identified from routine statutory health insurance data. However, the long-term consequences of KardioPro still need to be evaluated.
Source: BMC Health Services Research - June 17, 2014 Category: Journals (General) Authors: Majed AljutailiChristian BeckerSabine WittRolf HolleReiner LeidlMichael BlockJohannes BrachmannSigmund SilberKurt BestehornBjörn Stollenwerk Source Type: research

Five-year 'death test' provides few answers
ConclusionThis large population-based study was able to show which people were at increased risk of dying from cardiovascular, cancer or other causes over a five-year period. However, the researchers could not predict which illness a person may be at higher risk of getting or provide an opportunity for targeted prevention or treatment strategies. Strengths of the study include the large sample size and the fact participants were taken from the general population. The results also remained statistically significant after adjusting for age, sex, current disease and many other recognised indicators of chronic disease.However,...
Source: NHS News Feed - February 26, 2014 Category: Consumer Health News Tags: Heart/lungs Cancer Diabetes Medical practice Source Type: news

Physio- and Occupationaltherapy Pathways of Stroke Patients and Stroke Mortality.
This study examines the relationship between adherence to clinical guidelines and survival time in the first year after stroke.The sample comprises all clients of the Deutsche BKK, a large German health insurance company, who received acute inpatient care for stroke in 2007, who survived the hospital stay by at least 14 days, and who had motor deficits at the end of their acute treatment (n=1 791). 3 types of treatment that differ in the degree of adherence to clinical guidelines are identified ("Frühreha-Plus">"Standard-Plus">"Nur Akut").There is a positive relationship between adherence to clinical guidelines an...
Source: Die Rehabilitation - January 7, 2014 Category: Rehabilitation Authors: Peschke D, Schnitzer S, Kuhlmey A, Schenk L Tags: Rehabilitation (Stuttg) Source Type: research

Frequency and predictors of complications in neurological surgery: national trends from 2006 to 2011.
Conclusions Understanding the landscape of neurosurgical complications will allow better targeting of the most costly and harmful complications of preventive measures. Data from the ACS NSQIP database provide a starting point for developing paradigms of improved care of neurosurgical patients. PMID: 24266542 [PubMed - as supplied by publisher]
Source: Journal of Neurosurgery - November 22, 2013 Category: Neurosurgery Authors: Rolston JD, Han SJ, Lau CY, Berger MS, Parsa AT Tags: J Neurosurg Source Type: research

Abstract 198: Racial Disparity In Resuming Anticoagulation For Atrial Fibrillation After An Episode Of Major Gastrointestinal Bleeding Poster Session II
Conclusion: In conclusion, the racial disparity in resuming warfarin after an episode of major GIB in anticoagulated patients for atrial fibrillation was more for Caucasians than African American. This may be explained by uncertainty of outcomes that frequently leads to overtreatment of minority patients. Cultural beliefs for not resuming warfarin might have also played a role.
Source: Circulation: Cardiovascular Quality and Outcomes - May 15, 2013 Category: Cardiology Authors: Qureshi, W., Garikapati, K., Patsias, I., Cheema, G., Mittal, C., Alirhayim, Z., Paje, D. Tags: Poster Session II Source Type: research